SC 13G
SC 13G
- Company
- BioLineRx Ltd.
- Filed
- March 29, 2012
- Accession Number
- 0001178913-12-000881
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →